80% of current drug applications in China failed to meet analysis requirements

Re:80% of current drug applications in China failed to meet ... by HillRat on Sunday October 02, 2016 @11:17AM (#12622724)

I'm not sure that reputational risk is the same thing; I suspect one way to look at it is that a researcher who returns the null case is disrupting the organization by putting a lot of other peoples' work and assurances at risk. So there would be a significant amount of implicit social pressure to show results and maintain organizational harmony.

[ Parent | on HN ]

Re:80% of current drug applications in China failed to meet ... by beeftime on Sunday October 02, 2016 @11:47AM (#12622849)

having lived and worked in China for a few years, I can confirm you're dead on the money.

[ Parent | on HN ]

Re:80% of current drug applications in China failed to meet ... by 794CD01 on Sunday October 02, 2016 @12:03PM (#12622918)

That sounds like academia anywhere.

[ Parent | on HN ]

Re:80% of current drug applications in China failed to meet ... by finid on Sunday October 02, 2016 @06:13PM (#12624545)

Yep, publish or perish applies to academia everywhere.

[ Parent | on HN ]